Recalls / Active ingredient / Dolutegravir Sodium
Dolutegravir Sodium
4 FDA drug recalls involving the active ingredient “Dolutegravir Sodium”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-05-17 | Class III | Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle o | GlaxoSmithKline LLC |
| 2022-05-13 | Class III | Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 2770 | GlaxoSmithKline LLC |
| 2021-03-15 | Class II | Triumeq (abacavir, dolutegravir, and lamivudine) 600 mg/50 mg/300 mg Tablets 30 Tablets Rx Only NDC 49702-231- | Cardinal Health Inc. |
| 2014-02-11 | Class III | Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 2770 | Viiv Healthcare Company |